We are live on ! Find out more
TNDM icon

Tandem Diabetes Care
TNDM

379 hedge funds and large institutions have $6.84B invested in Tandem Diabetes Care in 2022 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 153 increasing their positions, 119 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

124% more call options, than puts

Call options by funds: $55.9M | Put options by funds: $24.9M

29% more repeat investments, than reductions

Existing positions increased: 153 | Existing positions reduced: 119

6% less first-time investments, than exits

New positions opened: 62 | Existing positions closed: 66

1.92% less ownership

Funds ownership: 95.11% → 93.2% (-1.9%)

2% less funds holding

Funds holding: 388 → 379 (-9)

25% less capital invested

Capital invested by funds: $9.07B → $6.84B (-$2.23B)

40% less funds holding in top 10

Funds holding in top 10: 10 → 6 (-4)

Holders
379
Holders Change
-9
Holders Change %
-2.32%
% of All Funds
5.98%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.09%
New
62
Increased
153
Reduced
119
Closed
66
Calls
$55.9M
Puts
$24.9M
Net Calls
+$31M
Net Calls Change
+$2.01M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$58M
2
Ameriprise
Ameriprise
Minnesota
+$56.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$51M
4
RG
Redmile Group
California
+$31.7M
5
Millennium Management
Millennium Management
New York
+$28.3M

Top Sellers

Rank Fund Capital Flow
1
JSP
Jackson Square Partners
California
-$117M
2
Capital World Investors
Capital World Investors
California
-$67.8M
3
Jennison Associates
Jennison Associates
New York
-$41.8M
4
CS
Credit Suisse
Switzerland
-$36.4M
5
Morgan Stanley
Morgan Stanley
New York
-$35.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
MML Investors Services
276
MML Investors Services
Massachusetts
$310K +$23.5K +201 +8%
Lazard Asset Management
277
Lazard Asset Management
New York
$304K +$194K +1,663 +175%
CA
278
Cetera Advisors
Colorado
$301K +$302K +2,586 New
CIBC Asset Management
279
CIBC Asset Management
Ontario, Canada
$295K – – –
OR
280
Olympiad Research
Connecticut
$293K +$77.1K +660 +36%
LWAC
281
Laurel Wealth Advisors (California)
California
$282K -$25.7K -220 -8%
NICM
282
Neo Ivy Capital Management
New York
$266K +$197K +1,691 +287%
SCA
283
Spearhead Capital Advisors
Florida
$256K -$283K -2,423 -52%
Mackenzie Financial
284
Mackenzie Financial
Ontario, Canada
$256K +$257K +2,200 New
AT
285
American Trust
Kentucky
$252K +$253K +2,163 New
Truist Financial
286
Truist Financial
North Carolina
$244K – – –
Los Angeles Capital Management
287
Los Angeles Capital Management
California
$243K +$13.1K +112 +6%
AP
288
Appleton Partners
Massachusetts
$242K – – –
WWM
289
Western Wealth Management
Colorado
$234K +$234K +2,008 New
BA
290
Bridgewater Advisors
New York
$233K – – –
CCP
291
Clarkston Capital Partners
Michigan
$233K – – –
M&T Bank
292
M&T Bank
New York
$233K – – –
MYIA
293
Mount Yale Investment Advisors
Colorado
$226K -$1.28K -11 -0.6%
A
294
Astrantus
Cyprus
$222K +$223K +1,911 New
LA
295
LVW Advisors
New York
$207K +$10.5K +90 +5%
H6H
296
Hightower 6M Holding
Kansas
$206K +$207K +1,769 New
DAM
297
Derbend Asset Management
Georgia
$203K – – –
OTL
298
Oak Thistle LLC
New York
$202K +$203K +1,738 New
B
299
Bailard
California
$200K +$201K +1,720 New
Simplex Trading
300
Simplex Trading
Illinois
$199K +$200K +1,713 New
10 11
12
13 14

TNDM Hedge Fund Activity: Q1 2022 in Review

379 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q1 2022, worth a combined $6.84B — down 25% from $9.07B a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of TNDM and 62 opened new positions — a net loss of 4 holders — while 119 trimmed existing stakes and 153 added.

The largest buyer was Fidelity Investments, adding an estimated $58M. The largest seller was Jackson Square Partners, cutting an estimated $117M.

  • 379 institutional investors held Tandem Diabetes Care (TNDM) as of Q1 2022, down from 388 in Q4 2021.
  • Funds reported $6.84B of Tandem Diabetes Care stock for Q1 2022, down 25% quarter-over-quarter.
  • 62 funds opened new Tandem Diabetes Care positions in Q1 2022 and 66 closed out, a net change of -4 holders.
  • The largest Tandem Diabetes Care buyer in Q1 2022 was Fidelity Investments, an estimated $58M added.
  • The largest Tandem Diabetes Care seller in Q1 2022 was Jackson Square Partners, an estimated $117M sold.

Based on aggregated 13F filings for Q1 2022.